Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

google news feed for p53 pulls up a discussion among hematologists trying to explain the cytogenetics of AML and response to treatment

They reference less than great response of bone marrow transplant in AML patients with p53 mutation

Another very picky example of trying to tease out treatment plans for cancer patients based on mutations underlying cancer.

Another example of why this stock might be a big winner.

On an unrelated note: I am still baffled at how the pharmacokinetics from once a week dosing of a short half life drug allow you to go straight to phase 2- but hey, what do I know?

Wil Mayo collaboration prove to be more helpful more than MD Anderson connection? Sounds like it from the press releases

Bring on the phase 2's. Prove you mean it, CTIX, when you say you need no more dosing data to start those trials